As 2026 marks the opening year of the 15th Five-Year Plan and the Implementation Plan for Digital and Intelligent Transformation of the Pharmaceutical Industry (2025–2030) is comprehensively advanced, the deep integration of artificial intelligence, digital twins, and Laboratory Information Management Systems (LIMS) is driving a profound paradigm shift in pharmaceutical laboratories—from mere digitization to intelligent digital transformation.
Concurrently, the 2025 edition of the Pharmacopoeia of the People's Republic of China has entered a critical window for full implementation, posing unprecedented challenges to the testing capabilities and quality control systems of pharmaceutical laboratories. Driven by the dual forces of evolving standards and technological innovation, China's pharmaceutical laboratories stand at a historic crossroads of paradigm revolution.
As the world's most influential trade fair for the analytical field, analytica China joins forces with Ouryao, a leading platform in the pharmaceutical industry. Leveraging their unique strengths in exhibition display and deep industry cultivation, the event brings together senior experts from standard-setting bodies, regulatory authorities, scientific research institutions, industry associations, and leading pharmaceutical enterprises. Under the theme "Innovation-led, Intelligence-empowered for a New Journey", we will jointly explore how to navigate industrial transformation, standard upgrades, and technological iterations against the dual backdrop of policy-driven mandates and technological breakthroughs, leading the industry toward a new era of high-quality development.
Organizers: Ouryao
Messe Muenchen Shanghai Co., Ltd.
Dates: November 16–17, 2026
Venue: Shanghai New International Expo Centre (SNIEC)
November 16, 2026
| Topics | Time | Speakers | |
|---|---|---|---|
|
Topics
Check-In |
Time
09:00-09:30 |
Speakers | |
|
Topics
Opening Speach |
Time
09:30-09:45 |
Speakers | |
|
Topics
Interpretation of the Implementation Plan for Digital and Intelligent Transformation of the Pharmaceutical Industry (2025–2030) |
Time
09:45-10:15 |
Speakers
Guo Wen, Director, China Pharmaceutical Information Center |
|
|
Topics
Ceremony |
Time
10:15-10:30 |
Speakers | |
|
Topics
Tea Break |
Time
10:30-10:40 |
Speakers | |
|
Topics
Building a New Paradigm of "Smart Pharmaceutical Testing" under the Background of Pharmaceutical Industry Innovation and Upgrading |
Time
10:40-11:10 |
Speakers
Dr. Qiu Xiao, Vice President, Shanghai Institute for Food and Drug Control |
|
|
Topics
Panel: Standard Upgrades & Digital-Intelligent Driving — Opportunities and Challenges for China's Pharmaceutical Laboratories |
Time
11:10-12:00 |
Speakers | |
|
Topics
Lunch Break |
Time
12:00-13:30 |
Speakers | |
|
Topics
Standard-Led High-Quality Development of Pharmaceutical Laboratories |
Time
13:30-14:00 |
Speakers
Wu Yaowei, Deputy Secretary-General, Shanghai Pharmaceutical Industry Association |
|
|
Topics
Golden 300 Seconds: Showcase of New Laboratory Products and Technologies |
Time
14:00-14:40 |
Speakers | |
|
Topics
Thoughts on Constructing an Innovation Ecosystem for Biomedical Laboratories in Higher Education Institutions |
Time
14:40-15:10 |
Speakers
Prof. Wu Wenhui, Pujiang Scholar, Professor and Doctoral Supervisor at Shanghai Ocean University |
|
|
Topics
Tea Break |
Time
15:10-15:20 |
Speakers | |
|
Topics
From Automation to Intelligence: Exploration and Practice of Next-Generation Smart Laboratories |
Time
15:20-15:50 |
Speakers
Dr. Fang Mingyue, Head of China Non-GMP Pilot Plant & BRD Digital and Intelligent Innovation Team, WuXi Biologics |
|
|
Topics
From Compliance to Excellence: Practical Insights on FDA Audit Preparation for Pharmaceutical Laboratories |
Time
15:50-16:20 |
Speakers
Dr. Huang Qing, Deputy General Manager, Nanjing Shunxin Pharma (ChiaTai TianQing Group) |
|
|
Topics
*Subject to the actual announcement on site. |
Time | Speakers | |
November 17, 2026
| Topics | Time | Speakers | |
|---|---|---|---|
|
Topics
Check-In |
Time
09:00-09:30 |
Speakers | |
|
Topics
Opening Speach |
Time
09:30-09:40 |
Speakers | |
|
Topics
Interpretation of the Guidelines for Quality Management of Pharmaceutical Research on Chemical Drugs |
Time
09:40-10:25 |
Speakers
Pan Hongjuan, Director of the Analytical Testing Center, Shanghai Institute of Pharmaceutical Industry |
|
|
Topics
Benchmarking Internationally: Operation and Management Strategies for Center of Excellence Laboratories in Pharmaceutical Enterprises |
Time
10:25-11:10 |
Speakers
Dong Fang, Quality Director, Hengrui Pharma |
|
|
Topics
Implementation of ICH Q2(R2) and Q14 in Laboratories: Transition Practices from Analytical Procedure Validation to Full Lifecycle Management |
Time
11:10-11:55 |
Speakers | |
|
Topics
Lunch Break |
Time
11:55-13:30 |
Speakers | |
|
Topics
*Subject to the actual announcement on site. |
Time | Speakers | |
November 17, 2026
| Topics | Time | Speakers | |
|---|---|---|---|
|
Topics
Check-In |
Time
13:00-13:30 |
Speakers | |
|
Topics
Opening Speach |
Time
13:30-13:40 |
Speakers | |
|
Topics
Exploration and Practice of Digital Transformation in Pharmaceutical Laboratories |
Time
13:40-14:25 |
Speakers
Li Bo, Compliance Director of Group Quality Compliance Department, Porton Pharma |
|
|
Topics
Application and Practice of Multi-Omics and AI in the Full Lifecycle of Drug R&D |
Time
14:25-15:10 |
Speakers
Dr. Zheng Yong, Founder and Chairman, Innomax Biomedical Technology |
|
|
Topics
Technical Requirements and Considerations for Quality Research and Quality Control in NDA Submissions for Cell Therapy Products |
Time
15:10-15:55 |
Speakers
Wu Ying, QC Director, Fosun Kairos Biotechnology |
|
|
Topics
*Subject to the actual announcement on site. |
Time | Speakers | |